Biosimilar adoption in the U.S. is increasing as more biologic drugs face patent expirations. This and more in this week’s life sciences update. … READ MORE >
biopharma
5 things to know in life sciences: Week of June 22, 2026
The Department of Health and Human Services is rolling out reforms to speed up early-stage clinical trials and reduce regulatory burden. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of June 15, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of June 8, 2026
Medtech M&A has remained strong through the first half of 2026. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of June 1, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of May 25, 2026
AI adoption in medtech is rapidly accelerating. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of May 11, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of May 4, 2026
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of April 27, 2026
Regulators have introduced a new pathway designed to accelerate Medicare coverage decisions for innovative medical devices. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of April 20, 2026
The FDA has advanced a plan to reduce animal testing. This and more in this week’s life sciences update. … READ MORE >